LEP and myeloid sarcoma: Given that the distinct roles of leptin and adiponectin in cardiometabolic disorders, we hypothesized that imbalance of leptin-adiponectin regulation, as reflected by the circulating levels of leptin to adiponectin ratio (L/A), could potentially be a better indicator for diagnosis of MS than leptin or adiponectin alone.